182 related articles for article (PubMed ID: 30785828)
1. Markedly Reduced Risk of Internal Malignancies in Patients With Vitiligo: A Nationwide Population-Based Cohort Study.
Bae JM; Chung KY; Yun SJ; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Kim M
J Clin Oncol; 2019 Apr; 37(11):903-911. PubMed ID: 30785828
[TBL] [Abstract][Full Text] [Related]
2. The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea.
Kim HS; Kim HJ; Hong ES; Kim KB; Lee JD; Kang TU; Ahn HS
Br J Dermatol; 2020 Apr; 182(4):907-915. PubMed ID: 31233609
[TBL] [Abstract][Full Text] [Related]
3. Reduced risk of skin cancer and internal malignancies in vitiligo patients: a retrospective population-based cohort study in Taiwan.
Weng YC; Ho HJ; Chang YL; Chang YT; Wu CY; Chen YJ
Sci Rep; 2021 Oct; 11(1):20195. PubMed ID: 34642421
[TBL] [Abstract][Full Text] [Related]
4. Evaluation for Skin Cancer and Precancer in Patients With Vitiligo Treated With Long-term Narrowband UV-B Phototherapy.
Bae JM; Ju HJ; Lee RW; Oh SH; Shin JH; Kang HY; Park JH; Kim HJ; Jeong KH; Lee HJ; Lee S; Kim DH; Lee DY; Kim YC; Choi GS; Kim KH; Park CJ; Choi CW;
JAMA Dermatol; 2020 May; 156(5):529-537. PubMed ID: 32159729
[TBL] [Abstract][Full Text] [Related]
5. Non-melanoma skin cancer as a clinical marker for internal malignancies: a nationwide population-based cohort study.
Yun SJ; Bae JM; Kim H; Park BC; Kim JS; Seo SH; Ahn HH; Lee DY; Kim YC; Park HJ; Chung KY
J Eur Acad Dermatol Venereol; 2020 Apr; 34(4):746-753. PubMed ID: 31494979
[TBL] [Abstract][Full Text] [Related]
6. Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo.
Paradisi A; Tabolli S; Didona B; Sobrino L; Russo N; Abeni D
J Am Acad Dermatol; 2014 Dec; 71(6):1110-6. PubMed ID: 25242557
[TBL] [Abstract][Full Text] [Related]
7. Markedly increased risk of malignancies in women with endometriosis.
Eoh KJ; Han M; Kim EH; Jung I; Kim YT
Gynecol Oncol; 2021 Apr; 161(1):291-296. PubMed ID: 33514482
[TBL] [Abstract][Full Text] [Related]
8. Vitiligo and overt thyroid diseases: A nationwide population-based study in Korea.
Bae JM; Lee JH; Yun JS; Han B; Han TY
J Am Acad Dermatol; 2017 May; 76(5):871-878. PubMed ID: 28238453
[TBL] [Abstract][Full Text] [Related]
9. Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea'.
Choi JW; Lee ES
Br J Dermatol; 2020 Dec; 183(6):1149-1150. PubMed ID: 32762038
[No Abstract] [Full Text] [Related]
10. Response to 'The incidence and survival of melanoma and nonmelanoma skin cancer in patients with vitiligo: a nationwide population-based matched cohort study in Korea' - reply from the authors.
Kim HS; Ahn HS
Br J Dermatol; 2020 Dec; 183(6):1150-1151. PubMed ID: 32767749
[No Abstract] [Full Text] [Related]
11. Prevalence of vitiligo and associated comorbidities in Korea.
Lee H; Lee MH; Lee DY; Kang HY; Kim KH; Choi GS; Shin J; Lee HJ; Kim DH; Kim TH; Lee AY; Lee SC; Lee S; Kim KW; Hann SK; Park CJ; Oh SH
Yonsei Med J; 2015 May; 56(3):719-25. PubMed ID: 25837178
[TBL] [Abstract][Full Text] [Related]
12. Increased Risk of Vitiligo Following Anti-Tumor Necrosis Factor Therapy: A 10-Year Population-Based Cohort Study.
Bae JM; Kim M; Lee HH; Kim KJ; Shin H; Ju HJ; Kim GM; Park CJ; Park HJ
J Invest Dermatol; 2018 Apr; 138(4):768-774. PubMed ID: 29175284
[TBL] [Abstract][Full Text] [Related]
13. Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners.
Teulings HE; Overkamp M; Ceylan E; Nieuweboer-Krobotova L; Bos JD; Nijsten T; Wolkerstorfer AW; Luiten RM; van der Veen JP
Br J Dermatol; 2013 Jan; 168(1):162-71. PubMed ID: 23136900
[TBL] [Abstract][Full Text] [Related]
14. Assessment of Overall and Specific Cancer Risks in Patients With Hidradenitis Suppurativa.
Jung JM; Lee KH; Kim YJ; Chang SE; Lee MW; Choi JH; Won CH; Lee WJ
JAMA Dermatol; 2020 Aug; 156(8):844-853. PubMed ID: 32459291
[TBL] [Abstract][Full Text] [Related]
15. Herpes Zoster and Subsequent Cancer Risk: A Nationwide Population-Based Cohort Study in Korea.
Kim M; Han K; Yoo SA; Lee JH
Dermatology; 2021; 237(1):73-78. PubMed ID: 32114571
[TBL] [Abstract][Full Text] [Related]
16. Subsequent vitiligo after hematopoietic stem cell transplantation: A nationwide population-based cohort study from Korea.
Bae JM; Choi KH; Jung HM; Kim SY; Kim M; Kim GM; Yu DS; Lee YB
J Am Acad Dermatol; 2017 Mar; 76(3):459-463. PubMed ID: 27836331
[TBL] [Abstract][Full Text] [Related]
17. Comorbidity profiles in association with vitiligo: a nationwide population-based study in Taiwan.
Chen YT; Chen YJ; Hwang CY; Lin MW; Chen TJ; Chen CC; Chu SY; Lee DD; Chang YT; Liu HN
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1362-9. PubMed ID: 25510261
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of comorbid rheumatic disorders in vitiligo patients: A nationwide population-based study.
Choi CW; Eun SH; Choi KH; Bae JM
J Dermatol; 2017 Aug; 44(8):909-913. PubMed ID: 28370282
[TBL] [Abstract][Full Text] [Related]
19. Positive association between actinic keratosis and internal malignancies: a nationwide population-based cohort study.
Lee YB; Lee JH; Kim YH; Seo JM; Yu DS; Park YG; Han KD
Sci Rep; 2021 Oct; 11(1):19769. PubMed ID: 34611257
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and incidence of vitiligo and associated comorbidities: a nationwide population-based study in Korea.
Kang H; Lee S
Clin Exp Dermatol; 2023 Apr; 48(5):484-489. PubMed ID: 36656897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
